These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 23735334)

  • 1. Evasion of adaptive and innate immune response mechanisms by γ-herpesviruses.
    Feng P; Moses A; Früh K
    Curr Opin Virol; 2013 Jun; 3(3):285-95. PubMed ID: 23735334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune escape of γ-herpesviruses from adaptive immunity.
    Hu Z; Usherwood EJ
    Rev Med Virol; 2014 Nov; 24(6):365-78. PubMed ID: 24733560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune evasion by gamma-herpesviruses.
    Stevenson PG
    Curr Opin Immunol; 2004 Aug; 16(4):456-62. PubMed ID: 15245739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A gamma-herpesvirus deficient in replication establishes chronic infection in vivo and is impervious to restriction by adaptive immune cells.
    Tibbetts SA; Suarez F; Steed AL; Simmons JA; Virgin HW
    Virology; 2006 Sep; 353(1):210-9. PubMed ID: 16797052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of murine gamma-herpesvirus infection.
    Nash AA; Dutia BM; Stewart JP; Davison AJ
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):569-79. PubMed ID: 11313012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation and Evasion of Innate Immunity by Gammaherpesviruses.
    Lange PT; White MC; Damania B
    J Mol Biol; 2022 Mar; 434(6):167214. PubMed ID: 34437888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attack, parry and riposte: molecular fencing between the innate immune system and human herpesviruses.
    Le-Trilling VT; Trilling M
    Tissue Antigens; 2015 Jul; 86(1):1-13. PubMed ID: 26061653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macavirus latency-associated protein evades immune detection through regulation of protein synthesis in cis depending upon its glycin/glutamate-rich domain.
    Sorel O; Chen T; Myster F; Javaux J; Vanderplasschen A; Dewals BG
    PLoS Pathog; 2017 Oct; 13(10):e1006691. PubMed ID: 29059246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of host antiviral resistances by gammaherpesvirus tegument proteins with homology to the FGARAT purine biosynthesis enzyme.
    Tsai K; Messick TE; Lieberman PM
    Curr Opin Virol; 2015 Oct; 14():30-40. PubMed ID: 26256000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early establishment of gamma-herpesvirus latency: implications for immune control.
    Flaño E; Jia Q; Moore J; Woodland DL; Sun R; Blackman MA
    J Immunol; 2005 Apr; 174(8):4972-8. PubMed ID: 15814726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evasion of innate cytosolic DNA sensing by a gammaherpesvirus facilitates establishment of latent infection.
    Sun C; Schattgen SA; Pisitkun P; Jorgensen JP; Hilterbrand AT; Wang LJ; West JA; Hansen K; Horan KA; Jakobsen MR; O'Hare P; Adler H; Sun R; Ploegh HL; Damania B; Upton JW; Fitzgerald KA; Paludan SR
    J Immunol; 2015 Feb; 194(4):1819-31. PubMed ID: 25595793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate immunity and alpha/gammaherpesviruses: first impressions last a lifetime.
    Jondle CN; Tarakanova VL
    Curr Opin Virol; 2020 Oct; 44():81-89. PubMed ID: 32777757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine herpesvirus pathogenesis: a model for the analysis of molecular mechanisms of human gamma herpesvirus infections.
    Rajćáni J; Kúdelová M
    Acta Microbiol Immunol Hung; 2005; 52(1):41-71. PubMed ID: 15957234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus.
    Tibbetts SA; van Dyk LF; Speck SH; Virgin HW
    J Virol; 2002 Jul; 76(14):7125-32. PubMed ID: 12072512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice.
    Gangappa S; Kapadia SB; Speck SH; Virgin HW
    J Virol; 2002 Nov; 76(22):11460-8. PubMed ID: 12388707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A replication-deficient murine gamma-herpesvirus blocked in late viral gene expression can establish latency and elicit protective cellular immunity.
    Kayhan B; Yager EJ; Lanzer K; Cookenham T; Jia Q; Wu TT; Woodland DL; Sun R; Blackman MA
    J Immunol; 2007 Dec; 179(12):8392-402. PubMed ID: 18056385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses.
    Stevenson PG; Efstathiou S; Doherty PC; Lehner PJ
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8455-60. PubMed ID: 10890918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse immune evasion strategies by human cytomegalovirus.
    Noriega V; Redmann V; Gardner T; Tortorella D
    Immunol Res; 2012 Dec; 54(1-3):140-51. PubMed ID: 22454101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral appropriation of apoptotic and NF-kappaB signaling pathways.
    Bowie AG; Zhan J; Marshall WL
    J Cell Biochem; 2004 Apr; 91(6):1099-108. PubMed ID: 15048867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling immunity to gamma-herpesviruses: a new model for understanding the role of immunity in chronic virus infection.
    Virgin HW; Speck SH
    Curr Opin Immunol; 1999 Aug; 11(4):371-9. PubMed ID: 10448140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.